Marco Cerbón

Dr. Marco Cerbón


Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 June 2017 in Endocrine
Verified
Journal Article
Closed access
PDF file
ECErika Alejandra Cabrera-Reyes
Erika Alejandra Cabrera-Reyes
OLOfelia Limón-Morales
Ofelia Limón-Morales
Nadia RiveroNadia Rivero
Nadia Rivero
ICIgnacio Camacho-Arroyo
Ignacio Camacho-Arroyo
MCMarco Cerbón
Marco Cerbón

Verified
Journal Article
Open access
PDF file
AMAlejandra Martínez-Ibarra
Alejandra Martínez-Ibarra
LRLuis Daniel Martínez Razo
Luis Daniel Martínez Razo
EVEDGAR RICARDO VAZQUEZ-MARTINEZ
EDGAR RICARDO VAZQUEZ-MARTINEZ
NMNayeli Martinez-Cruz
Nayeli Martinez-Cruz
ROGELIO FLORES RAMIREZROGELIO FLORES RAMIREZ
ROGELIO FLORES RAMIREZ
MCMarco Cerbón
Marco Cerbón
Several studies indicate that bisphenol A (BPA) and phthalates may have a role in the development of metabolic diseases using different molecular pathways, including epigenetic regulatory mechanisms. However, it is unclear whether exposure to these chemicals modifies serum levels of miRNAs associated with gestational diabetes mellitus (GDM) risk. In the present study, we evaluated the serum levels of miRNAs associated with GDM (miR-9-5p, miR-16-5p, miR-29a-3p and miR-330-3p) and urinary levels of phthalate metabolites (mono-n-butyl phthalate (MBP), mono-isobutyl phthalate (MiBP), mono-benzyl phthalate (MBzP) and mono(2-ethyl hexyl) phthalate (MEHP)) and bisphenol A in GDM patients and women without GDM during the second trimester of gestation. We observed higher levels of miR-9-5p, miR-29a-3p and miR-330-3p in sera of patients with GDM compared to non-diabetic subjects. Phthalates were detected in 97–100% of urine samples, while BPA only in 40%. Urinary MEHP and BPA concentrations were remarkably higher in both study groups compared to previously reported data. Unadjusted MEHP levels and adjusted BPA levels were higher in non-diabetics than in GDM patients (p = 0.03, p = 0.02). We found positive correlations between adjusted urinary MBzP levels and miR-16-5p expression levels (p < 0.05), adjusted MEHP concentrations and miR-29a-3p expression levels (p < 0.05). We also found negative correlations between unadjusted and adjusted MBP concentrations and miR-29a-3p expression levels (p < 0.0001, p < 0.05), unadjusted MiBP concentrations and miR-29a-3p expression levels (p < 0.01). Urinary MEHP levels reflect a striking exposure to di(2-ethylhexyl) phthalate (DEHP) in pregnant Mexican women. This study highlights the need for a regulatory strategy in the manufacture of several items containing endocrine disruptors in order to avoid involuntary ingestion of these compounds in the Mexican population.

1 February 2021 in Environmental Pollution
Verified
Journal Article
Open access
AMA. Martínez-Ibarra
A. Martínez-Ibarra
LML.D. Martínez-Razo
L.D. Martínez-Razo
KMKarla MacDonald
Karla MacDonald
MMMiguel Morales
Miguel Morales
EVE.R. Vázquez-Martínez
E.R. Vázquez-Martínez
MCMarco Cerbón
Marco Cerbón
A vast amount of evidence indicates that bisphenol A (BPA) and phthalates are widely distributed in the environment since these compounds are mass-produced for the manufacture of plastics and plasticizers. These compounds belong to a large group of substances termed endocrine-disrupting chemicals (EDC). It is well known that humans and living organisms are unavoidably and unintentionally exposed to BPA and phthalates from food packaging materials and many other everyday products. BPA and phthalates exert their effect by interfering with hormone synthesis, bioavailability, and action, thereby altering cellular proliferation and differentiation, tissue development, and the regulation of several physiological processes. In fact, these EDC can alter fetal programming at an epigenetic level, which can be transgenerational transmitted and may be involved in the development of various chronic pathologies later in the adulthood, including metabolic, reproductive and degenerative diseases, and certain types of cancer. In this review, we describe the most recent proposed mechanisms of action of these EDC and offer a compelling selection of experimental, epidemiological and clinical studies, which show evidence of how exposure to these pollutants affects our health during development, and their association with a wide range of reproductive, metabolic and neurological diseases, as well as hormone-related cancers. We stress the importance of concern in the general population and the urgent need for the medical health care system to closely monitor EDC levels in the population due to unavoidable and involuntary exposure to these pollutants and their impact on human health.

18 December 2020 in Reviews in the Neurosciences
Verified
Journal Article
Open access
PDF file
EMEdgar Gustavo Ramos Martínez
Edgar Gustavo Ramos Martínez
IMIvan Ramos Martínez
Ivan Ramos Martínez
GMGladys Molina-Salinas
Gladys Molina-Salinas
WZWendy A. Zepeda-Ruiz
Wendy A. Zepeda-Ruiz
MCMarco Cerbón
Marco Cerbón
Prolactin has been shown to favor both the activation and suppression of the microglia and astrocytes, as well as the release of inflammatory and anti-inflammatory cytokines. Prolactin has also been associated with neuronal damage in diseases such as multiple sclerosis, epilepsy, and in experimental models of these diseases. However, studies show that prolactin has neuroprotective effects in conditions of neuronal damage and inflammation and may be used as neuroprotector factor. In this review, we first discuss general information about prolactin, then we summarize recent findings of prolactin function in inflammatory and anti-inflammatory processes and factors involved in the possible dual role of prolactin are described. Finally, we review the function of prolactin specifically in the central nervous system and how it promotes a neuroprotective effect, or that of neuronal damage, particularly in experimental autoimmune encephalomyelitis and during excitotoxicity. The overall studies indicated that prolactin may be a promising molecule for the treatment of some neurological diseases.

5 May 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Nadia RiveroNadia Rivero
Nadia Rivero
EFEdgar Flores-Soto
Edgar Flores-Soto
SCSelene García De La Cadena
Selene García De La Cadena
ICIsabel Coronado-Mares
Isabel Coronado-Mares
CVCarlos Verjan
Carlos Verjan
MCMarco Cerbón
Marco Cerbón
Prolactin (PRL) is a peptidic hormone that displays pleiotropic functions in the organism including different actions in the brain. PRL exerts a neuroprotective effect against excitotoxicity produced by glutamate (Glu) or kainic acid in both in vitro and in vivo models. It is well known that Glu excitotoxicity causes cell death through apoptotic or necrotic pathways due to intracellular calcium ([Ca2+] i) overload. Therefore, the aim of the present study was to assess the molecular mechanisms by which PRL maintains cellular viability of primary cultures of rat hippocampal neurons exposed to Glu excitotoxicity. We determined cell viability by monitoring mitochondrial activity and using fluorescent markers for viable and dead cells. The intracellular calcium level was determined by a fluorometric assay and proteins involved in the apoptotic pathway were determined by immunoblot. Our results demonstrated that PRL afforded neuroprotection against Glu excitotoxicity, as evidenced by a decrease in propidium iodide staining and by the decrease of the LDH activity. In addition, the MTT assay shows that PRL maintains normal mitochondrial activity even in neurons exposed to Glu. Furthermore, the Glu-induced intracellular [Ca2+]i overload was attenuated by PRL. These data correlate with the reduction found in the level of active caspase-3 and the pro-apoptotic ratio (Bax/Bcl-2). Concomitantly, PRL elicited the nuclear translocation of the transcriptional factor NF-κB, which was detected by immunofluorescence and confocal microscopy. To our knowledge, this is the first report demonstrating that PRL prevents Glu excitotoxicity by a mechanism involving the restoration of the intracellular calcium homeostasis and mitochondrial activity, as well as an anti-apoptotic action possibly mediated by the activity of NF-κB. Overall, the current results suggest that PRL could be of potential therapeutic advantage in the treatment of neurodegenerative diseases.

Verified
Journal Article
Open access
PDF file
IMIvan Ramos Martínez
Ivan Ramos Martínez
MRMaría Carmen Rodriguez
María Carmen Rodriguez
MCMarco Cerbón
Marco Cerbón
JRJuan Carlos Ramos-Martínez
Juan Carlos Ramos-Martínez
EMEdgar Gustavo Ramos Martínez
Edgar Gustavo Ramos Martínez
In several central nervous system diseases, it has been reported that inflammation may be related to the etiologic process, therefore, therapeutic strategies are being implemented to control inflammation. As the nervous system and the immune system maintain close bidirectional communication in physiological and pathological conditions, the modulation of inflammation through the cholinergic anti-inflammatory reflex has been proposed. In this review, we summarized the evidence supporting chemical stimulation with cholinergic agonists and vagus nerve stimulation as therapeutic strategies in the treatment of various central nervous system pathologies, and their effect on inflammation.